BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997
46617 results:

  • 1. Implementation Strategies to Promote Short-Course Radiation for bone Metastases.
    Gillespie EF; Santos PMG; Curry M; Salz T; Chakraborty N; Caron M; Fuchs HE; Ledesma Vicioso N; Mathis N; Kumar R; O'Brien C; Patel S; Guttmann DM; Ostroff JS; Salner AL; Panoff JE; McIntosh AF; Pfister DG; Vaynrub M; Yang JT; Lipitz-Snyderman A
    JAMA Netw Open; 2024 May; 7(5):e2411717. PubMed ID: 38787561
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. bone and Extracellular Signal-Related Kinase 5 (ERK5).
    Wen L; Liu Z; Zhou L; Liu Z; Li Q; Geng B; Xia Y
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785963
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hallucination Rates and Reference Accuracy of ChatGPT and Bard for Systematic Reviews: Comparative Analysis.
    Chelli M; Descamps J; Lavoué V; Trojani C; Azar M; Deckert M; Raynier JL; Clowez G; Boileau P; Ruetsch-Chelli C
    J Med Internet Res; 2024 May; 26():e53164. PubMed ID: 38776130
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
    Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
    Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Promoter hypermethylation as a novel regulator of ANO1 expression and function in prostate cancer bone metastasis.
    Shin Y; Kim S; An W
    Sci Rep; 2024 May; 14(1):11595. PubMed ID: 38773164
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
    Xiao Y; Zhi Y; Cao G; Ma H; Gao J; Li F
    J Cancer Res Clin Oncol; 2024 May; 150(5):267. PubMed ID: 38769118
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Postoperative Outcomes of Total Humerus Replacement for Oncologic Reconstruction of the Upper Limb: A Systematic Review of the Literature.
    Gonzalez MR; Werenski JO; Lozano-Calderon SA
    JBJS Rev; 2024 May; 12(5):. PubMed ID: 38768282
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Breaking barriers: supporting hematopoietic stem cell transplant program through collaborative radiation therapy service from a physically distant center.
    Pandit S; Sapkota S; Adhikari A; Karki P; Shrestha R; Jha DS; Prajapati R; Nyaichyai KS; Poudyal BS; Poudel B; Jha AK
    J Egypt Natl Canc Inst; 2024 May; 36(1):17. PubMed ID: 38764073
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathy.
    Goldberg AJ; Masci L; O'Donnell P; Green R; Brooking D; Bassett P; Lowdell MW; Smith RKW
    Sci Rep; 2024 May; 14(1):11421. PubMed ID: 38763976
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
    Dong B; Zhou SF
    BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
    Pasvolsky O; Wang Z; Milton DR; Tanner MR; Bashir Q; Srour S; Saini N; Lin P; Ramdial J; Nieto Y; Tang G; Kebriaei P; Aljawai Y; Khan HN; Lee HC; Ye C; Patel KK; Thomas SK; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH
    Blood Cancer J; 2024 May; 14(1):82. PubMed ID: 38760362
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.
    Bao Z; Yu X; Zheng K; Zhai K; Cui H; Xu M
    Front Immunol; 2024; 15():1372279. PubMed ID: 38756778
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. 3D-Printed custom-made hemipelvic endoprosthetic reconstruction following periacetabular tumor resection: utilizing a novel classification system.
    Hu X; Lu M; Wang Y; Luo Y; Zhou Y; Yang X; Min L; Tu C
    BMC Musculoskelet Disord; 2024 May; 25(1):384. PubMed ID: 38755628
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
    Salim N; Tumanova K; Popodko A; Libson E
    JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.
    Nasri E; Torrence DE; Vasilopoulos T; Knapik JA; Lagmay JP; Reith JD; Gibbs CP
    Cancer J; 2024 May-Jun 01; 30(3):133-139. PubMed ID: 38753746
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Application of mixed reality technology in free fibular flap transplantation for repairing mandibular defects].
    Song X; Xiang D; Liu D; Liu Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 May; 38(5):588-592. PubMed ID: 38752246
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    Dang J; Xu G; Guo G; Zhang H; Shang L
    J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic accuracy of contrast-enhanced computed tomography in assessing bone invasion in patients with oral squamous cell carcinoma.
    Struckmeier AK; Buchbender M; Agaimy A; Kesting M
    Clin Oral Investig; 2024 May; 28(6):314. PubMed ID: 38748270
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
    Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
    Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2331.